Research Article

[Retracted] A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway

Figure 1

Oral administration of metabolitin attenuated abnormal glycolipid metabolism in T2DM/NAFLD mice. (a) The mouse weight at indicated time points (0–12 weeks). (b) The AUC during the oral GTT. (c) The AUC during the oral ITT. (d) The concentration of TC in the mouse serum. (e) The concentration of TG in the mouse serum. compared to the normal group; compared to the model group.
(a)
(b)
(c)
(d)
(e)